Aryx Therapeutics, Inc.
Records under this name other than patents Aryx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Aryx Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,498,449 | Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,156,840 | D2 Antagonists, Methods of Synthesis and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,549,912 | Methods for Treating Atrial Fibrillation Formerly held In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 7,326,787 | Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders Formerly held Term ended Term ended Aug 31, 2026 · High confidence | Term ended | Term ended Aug 31, 2026 | High confidence |
| US 7,629,466 | Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders Formerly held Term ended Term ended Aug 31, 2026 · Medium confidence | Term ended | Term ended Aug 31, 2026 | Medium confidence |
| US 8,691,836 | D2 Antagonists, Methods of Synthesis and Methods of Use Formerly held Lapsed on the fee record Ended Apr 8, 2026 · High confidence | Lapsed on the fee record | Ended Apr 8, 2026 | High confidence |
| US 7,176,218 | Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders Formerly held Term ended Term ended Aug 21, 2025 · High confidence | Term ended | Term ended Aug 21, 2025 | High confidence |
| US 8,138,204 | Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders Formerly held Term ended Term ended Aug 21, 2025 · High confidence | Term ended | Term ended Aug 21, 2025 | High confidence |
| US 7,282,509 | Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders Formerly held Term ended Term ended May 27, 2025 · High confidence | Term ended | Term ended May 27, 2025 | High confidence |
| US 7,105,568 | Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use Formerly held Term ended Term ended Apr 8, 2025 · High confidence | Term ended | Term ended Apr 8, 2025 | High confidence |